You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Belantamab mafodotin

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Corneal Findings in Patients Treated With Belantamab Mafodotin

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Belantamab mafodotin
  • (no location specified)
Apr 25, 2023

Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Belantamab mafodotin, Venetoclax
  • (no location specified)
May 10, 2023

Plasma Cell Myeloma Trial in Buffalo (Belantamab Mafodotin, Lenalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 5, 2022

Relapsed/Refractory Multiple Myeloma Trial in United States (Belantamab mafodotin)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Belantamab mafodotin
  • Clayton, North Carolina
  • +4 more
May 16, 2023

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
Aug 8, 2023

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

Not yet recruiting
  • AL Amyloidosis
  • Amyloidosis
  • Belantamab mafodotin 2.5 mg/kg (6 weeks)
  • +4 more
  • Stanford, California
  • +3 more
Jul 25, 2022

Multiple Myeloma Trial in United States (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • San Francisco, California
  • +5 more
Dec 9, 2022

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Jacksonville (Belantamab Mafodotin, Biospecimen

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 27, 2023

Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in Milwaukee (Belantamab mafodotin)

Recruiting
  • Refractory Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Aug 3, 2022

Corneal Toxicity in Patients Treated by Belantamab Mafodotin

Completed
  • Myeloma Multiple
  • Collection of datas
  • Dijon, France
  • +9 more
May 31, 2023

AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

Recruiting
  • AL Amyloidosis
  • Belantamab mafodotin
  • Limoges, France
  • +5 more
Sep 26, 2022

Myeloma Trial in Philadelphia (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jun 13, 2022

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Myeloma Trial in Houston (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Multiple Myeloma Trial in Houston (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Houston, Texas
    M D Anderson Cancer Center
Jan 5, 2023

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Oct 5, 2022

Relapsed/Refractory Multiple Myeloma Trial in Baltimore (Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
  • Baltimore, Maryland
    University of Maryland
Jan 24, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Belantamab Mafodotin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 10, 2022

Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed Multiple Myeloma
  • Belantamab mafodotin
  • +2 more
  • Badalona, Spain
  • +14 more
Sep 5, 2022

Multiple Myeloma Trial (Bela, Belamaf, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 27, 2023